International HIT-MED Registry: For children, adolescents, and adults with medulloblastoma, ependymoma, pineoblastoma, CNS-primitive neuroectodermal tumours

A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301)

The Registry of the European Mantle Cell Lymphoma Network (EMCL-R)

An Open-label, Multicenter, Phase 3 Randomized, Active-Comparator-Controlled Clinical Study of Pembrolizumab (MK-3475) in Combination With Sacituzumab Govitecan Versus MK-3475 Monotherapy as First-line Treatment in Participants With PD L1 TPS Greater than or Equal to 50% Metastatic Non-small Cell Lung Cancer (KEYNOTED46/EVOKE-03)

AML-Register und Biomaterialdatenbank der Studienallianz Leukämie (SAL) und der AML Cooperative Group (AML-CG)

KRANIOPHARYNGEOM Registry 2019
Multicenter registry for patients with childhood-onset craniopharyngioma, xanthogranuloma, cysts of Rathke’s pouch, meningioma, pituitary adenoma, arachnoid cysts

56021927PCR3020 (LIBERTAS) Eine offene, randomisierte, prospektive Phase-3-Studie zu Apalutamid mit fortgesetzter versus intermittierender Androgenentzugstherapie (ADT) nach PSA-Ansprechen bei Teilnehmern mit metastasiertem kastrationsempfindlichem Prostatakrebs (mCSPC)

A Phase 3, Randomized, International Multicenter Trial for Patients with Pediatric Low Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy